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Exercise Training Reveals Inﬂexibility of the Diaphragm in an Animal
Model of Patients With Obesity-Driven Heart Failure With a Preserved
Ejection Fraction
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Background-—Respiratory muscle weakness contributes to exercise intolerance in patients with heart failure with a preserved
ejection fraction (HFpEF)—a condition characterized by multiple comorbidities with few proven treatments. We aimed, therefore, to
provide novel insight into the underlying diaphragmatic alterations that occur in HFpEF by using an obese cardiometabolic rat
model and further assessed whether exercise training performed only after the development of overt HFpEF could reverse
impairments.
Methods and Results-—Obese ZSF1 rats (n=12) were compared with their lean controls (n=8) at 20 weeks, with 3 additional
groups of obese ZSF1 rats compared at 28 weeks following 8 weeks of either sedentary behavior (n=13), high-intensity interval
training (n=11), or moderate-continuous training (n=11). Obese rats developed an obvious HFpEF phenotype at 20 and 28 weeks.
In the diaphragm at 20 weeks, HFpEF induced a shift towards an oxidative phenotype and a ﬁber hypertrophy paralleled by a lower
protein expression in MuRF1 and MuRF2, yet mitochondrial and contractile functional impairments were observed. At 28 weeks,
neither the exercise training regimen of high-intensity interval training or moderate-continuous training reversed any of the
diaphragm alterations induced by HFpEF.
Conclusions-—This study, using a well-characterized rat model of HFpEF underpinned by multiple comorbidities and exercise
intolerance (ie, one that closely resembles the patient phenotype), provides evidence that diaphragm alterations and dysfunction
induced in overt HFpEF are not reversed following 8 weeks of aerobic exercise training. As such, whether alternative therapeutic
interventions are required to treat respiratory muscle weakness in HFpEF warrants further investigation. ( J Am Heart Assoc.
2017;6:e006416. DOI: 10.1161/JAHA.117.006416.)
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H eart failure with a preserved ejection fraction (HFpEF) isnow estimated to account for over half of cases of this
disease, with its prevalence predicted to increase even
further.1 It is disquieting, therefore, that evidence from large
clinical drug trials in HFpEF has been largely negative in terms
of beneﬁcial outcomes,2,3 which is in stark contrast to
ﬁndings in patients with a reduced ejection fraction (HFrEF).
This may be related, at least in part, to HFpEF being
characterized by multiple comorbidities such as obesity, type
II diabetes mellitus, hypertension, and chronic kidney disease,
which, in turn, are suggested to induce systemic inﬂammation
and impair multiple extracardiac organs that conspire to drive
the HFpEF phenotype.4 Exercise training has been one of the
few therapeutic therapies associated with clinical beneﬁts in
HFpEF2 and this seems unrelated to cardiac improvements
but rather to peripheral adaptations.5 Current evidence,
therefore, appears to support the current paradigm that
HFpEF and its main symptom exercise intolerance are driven
by noncardiac peripheral abnormalities.4
Recent data indicate that respiratory muscle weakness is
present in patients with HFpEF. Noninvasive functional
measures are reduced compared with age-matched controls
and these are correlated to exercise intolerance, increased
sensations of breathless, and an elevated respiratory drive.6,7
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Our laboratory recently conﬁrmed these studies with direct
evidence, where a hypertensive rat model of HFpEF demon-
strated diaphragm contractile dysfunction that was linked to
mitochondrial complex I functional impairments, ﬁber atrophy,
and a ﬁber type shift from a glycolytic towards an oxidative
phenotype.8 Importantly, exercise training performed in the
period preceding the onset of HFpEF (ie, primary prevention)
was able to abolish diaphragmatic impairments,8 thus
providing strong support for exercise training as a key
treatment of respiratory muscle weakness in HFpEF. However,
the clinical translation of this study was limited by the fact
that HFpEF was induced exclusively by hypertension, thereby
lacking the multiple comorbidities that typically characterize
patients with HFpEF. Furthermore, the exercise training
intervention was performed during the development rather
than after the onset of HFpEF, with no evidence provided in
regards to the optimal training regimen.
The present study, therefore, aimed to ﬁrst determine the
effects of HFpEF on the diaphragm in the more clinically
relevant ZSF1 rat model that is known to develop a typical
HFpEF phenotype after 20 weeks, which is characterized by
multiple comorbidities including obesity, hypertension, type 2
diabetes mellitus, and chronic kidney disease.9–12 In addition,
this study aimed to determine, by assessing 2 different
exercise training regimens of high or moderate intensity, the
effects of exercise training on the diaphragm after the onset
of overt HFpEF, thereby allowing the effects of secondary
prevention to be assessed—as is typical in clinical practice.
We supposed that answering both of these aims would
improve clinical translation and advance our underlying
knowledge and treatment of diaphragm dysfunction in HFpEF.
Methods
Study Design
All procedures and experiments were approved by the
Norwegian Animal Research Authority in accordance with the
national regulations, the European Convention for the Protec-
tion of Vertebrate Animals used for Experimental and Other
Scientiﬁc Purposes (ETS No.123), and the European Directive
2010/63/EU on the protection of animals used for scientiﬁc
purposes. Obese diabetic Zucker fatty/spontaneously hyper-
tensive heart failure F1 hybrid (ZSF1) rats (Charles River
Laboratories; bought at 8 weeks of age) were used as a model
to induce HFpEF, with this strain of rat previously shown to
develop typical clinical signs of HFpEF at 20 weeks of age.9–12
While both lean and obese ZSF1 rats inherit the hypertension
gene, only the obese ZSF1 rats inherit a mutation in the leptin
receptor gene that drives weight gain and metabolic impair-
ments. A schematic of the study design is presented in
Figure 1. Brieﬂy, male obese ZSF1 (ie, HFpEF; n=12) rats were
ﬁrst euthanized at 20 weeks of age and compared with lean
ZSF1 rat counterparts (ie, controls; n=8). Furthermore, at
28 weeks of age, 3 additional groups were euthanized, which
included sedentary obese rats (n=13) and also exercise trained
obese rats that performed either high-intensity interval
training (HFpEF+HIIT; n=11) or moderate continuous training
(HFpEF+MCT; n=11). Rats were exposed to identical condi-
tions in a 12-hour light/dark cycle, fed with standard chow
(RM1 chow, SDS) and administered water ad libitum.
Exercise Training
At 20 and 28 weeks, exercise capacity was measured in all
groups as assessed by peak pulmonary oxygen uptake
( _VO2peak) during a peak treadmill exercise test, as previously
described.8 For exercise training, obese ZSF1 rats were
randomized at 20 weeks of age to perform either HIIT (39per
week; 4 intervals at 90% _VO2peak for 4 minutes, with
3 minutes of recovery at 60% _VO2peak) or MCT (59per week
at 60% _VO2peak for 1 hour) for a total of 8 weeks on a
treadmill at a gradient of 25°. Exercise was preceded and
followed by 10 minutes of running at 40% to 50% _VO2peak.
Cardiovascular Function
In vivo 2-dimensional and M-mode echocardiography, con-
ventional Doppler echocardiography, and tissue Doppler
Clinical Perspective
What Is New?
• This study, using a rat model of heart failure with a
preserved ejection fraction underpinned by multiple comor-
bidities and exercise intolerance (ie, one that closely
resembles the patient phenotype), provides novel and
invasive evidence that diaphragm alterations and dysfunc-
tion induced by heart failure with a preserved ejection
fraction cannot be overcome by the intervention of aerobic
exercise training following overt disease development (ie,
secondary prevention), which is in contrast to previous
studies documenting a beneﬁt of exercise training per-
formed in the period preceding the onset of heart failure
with a preserved ejection fraction (ie, primary prevention).
What Are the Clinical Implications?
• If these animal ﬁndings translate to patients, it would
suggest that alternative therapeutic interventions rather
than aerobic exercise training may be required to treat
respiratory muscle weakness in heart failure with a
preserved ejection fraction.
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imaging data (Vevo 2100, VisualSonics) were obtained in
lightly anesthetized (1.5–2% isoﬂurane) but spontaneously
breathing rats in the supine position using a 24-MHz
transducer to assess cardiac function as previously
described,8 which included functional measures of diastole
(ie, peak velocity of early mitral ﬂow to tissue velocity [E/E0]
and ratio between peak E and A waves of mitral valve velocity
[E/A]) and systole (ie, left ventricular [LV] ejection fraction).8
Myocardial velocity (E0) was measured by tissue Doppler
imaging at the level of the basal septal segment in the septal
wall of the left ventricle in the apical 4-chamber view, while for
early (E) and late (A) ﬁlling of the left ventricle the Doppler
sample volume was positioned parallel to ﬂow direction and
the mitral valve. LV structural parameters were measured
from the short-axis view in M mode to calculate LV ejection
fraction. In addition, invasive hemodynamic pressure mea-
surements were measured as the terminal procedure. Under
light anesthesia (1.5–2% isoﬂurane), the right carotid artery
was cannulated with a conductance catheter (1.49 F,
Transonic Scisense Inc.) and a pressure transducer pene-
trated the aortic valve into the left ventricle. The LV end-
diastolic pressure, maximum rate of pressure rise (dP/dtmax),
maximum rate of pressure fall (dP/dtmin), and time constant
(s) for LV relaxation, after which withdrawal of the catheter
into the aorta, and phasic and mean arterial pressures were
measured. Data were recorded in LabChart 7 software (AD
Instruments). In addition, blood glucose levels were measured
using a FreeStyle Mini Meter (nonfasted state at 20 weeks,
and a 12-hour fasted state at 28 weeks). Tissue weights of
the left ventricle and the lungs (wet and dry) as well as tibia
length were further determined at euthanization.
Diaphragm Analyses
For functional assessment, the left costal diaphragm muscle
was prepared in a Krebs-Hanseleit buffer solution (120.5
NaCl, 4.8 KCl, 1.2 MgSO4, 1.2 NaH2PO4, 20.4 NaHCO3, 1.6
CaCl2, 10 dextrose, and 1 pyruvate [in mmol/L] at a pH of
7.40) at room temperature equilibrated with 95% O2 to 5%
CO2. Brieﬂy, a muscle bundle connected from the rib to the
central tendon was dissected, attached to silk sutures (4-0) at
either end, and mounted vertically in a buffer-ﬁlled organ
bath.8 In addition, the right soleus muscle was also dissected
and assessed in parallel. The suture connected to the rib was
HFpEF+Sed (n=13)
Con (n=8)
HFpEF+HIIT (n=11)
HFpEF+MCT (n=11)
Study Aim 1
HFpEF developed
Study Aim 2
Exercise intervention
HFpEF (n=12)
1. Lean 
2. Obese
3. Obese
4. Obese
5. Obese
Exercise training (HIIT or MCT) - 8 weeksGroup
0 
Time, wk
20 28 
Figure 1. Schematic outline summarizing the present study. Aim 1 of the study evaluated at 20 weeks
the effects of an obese cardiometabolic rat model of heart failure with a preserved ejection fraction (HFpEF)
on the diaphragm compared with lean controls (Con), while aim 2 of the study evaluated at 28 weeks
whether 8 weeks of exercise training (either high-intensity interval training [HIIT] or moderate-continuous
training [MCT]) could reverse diaphragm alterations as a secondary prevention compared with sedentary
(Sed) HFpEF rats. Dashed lines indicate the time point when animals were evaluated (20 or 28 weeks of
age), which included assessment of exercise capacity, cardiac function (echocardiography/invasive
hemodynamics), muscle function, and subsequent tissue analyses. The sample size (n) for each group are
provided in parentheses.
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secured to a hook at the bottom of the bath, while the tendon
was tied to a force transducer (FORT250, World Precision
Instruments Inc.), with the output continuously recorded and
digitized (PowerLab 8/30, ADInstruments). In vitro muscle
function was assessed by platinum electrodes stimulating the
muscle with a supramaximal current (700 mA, 500 ms train
duration, 0.25 ms pulse width) from a base stimulator (Grass
S88, Grass Technologies) ampliﬁed via a high-power bipolar
stimulator (701C, Aurora Scientiﬁc Inc.). The muscle bundle
was set at an optimal length equivalent to the maximal twitch
force produced, after which the bath temperature was
increased to 25°C and a 15-minute thermo-equilibration
period followed. A force-frequency protocol was then per-
formed at 1, 15, 30, 50, 80, 120, 150, and 300 Hz,
respectively, separated with 1-minute rest intervals. Following
a 5-minute period in which muscle length was measured using
digital calipers, the muscle underwent a fatigue protocol over
5 minutes (40 Hz every 2 seconds). Each muscle was sub-
sequently detached, trimmed free from the tendon, blotted
dry, and weighed. Muscle force (N) was normalized to muscle
cross-sectional area (cm2) by dividing muscle mass (g) by the
product of optimal length (cm) and estimated muscle density
(1.06),1 which allowed speciﬁc force in N/cm2 to be
calculated. Forces generated during the fatigue protocol were
normalized to the initial force generated, to provide a relative
assessment of fatigability. A further diaphragm bundle was
also dissected and permeabilized in saponin, and in situ
mitochondrial respiration measurements were performed
using high-resolution respirometry (Oxygraph-2k, Oroboros
Instruments), as described in expansive detail elsewhere.8
In addition, the right costal diaphragm was immediately
frozen in liquid N2. Frozen muscle samples were subsequently
homogenized in lysis buffer (50 mmol/L Tris, 150 mmol/L
sodium chloride, 1 mmol/L EDTA, 1% NP-40, 0.25% sodium-
deoxycholate, 0.1% SDS, 1% Triton X-100; pH 7.4) containing
a protease inhibitor mix (Inhibitor Mix M, Serva), sonicated,
and centrifuged at 16 000g for 5 minutes. The supernatant
was isolated and protein content determined (BCA assay,
Pierce). Diaphragm homogenates (5–20 lg) mixed with
loading buffer (126 mmol/L Tris-HCl, 20% glycerol, 4% SDS,
1.0% 2-mercaptoethanol, 0.005% bromophenol blue; pH 6.8)
were separated by SDS-polyacrylamide gel electrophoresis for
1.5 hours at 90 V. Proteins were transferred to a polyvinyli-
dene ﬂuoride membrane and incubated overnight at 4°C with
the following primary antibodies: peroxisome proliferator-
activated receptor gamma coactivator 1-a (PGC1-a;1/200,
Santa Cruz) and MuRF1 and MuRF2 (1/1000, Myomedix Ltd.).
Membranes were subsequently incubated with a horseradish
peroxidase–conjugated secondary antibody and speciﬁc
bands visualized by enzymatic chemiluminescence (Super
Signal West Pico, Thermo Fisher Scientiﬁc Inc.) and densit-
ometry quantiﬁed using a 1-dimensional scan software
package (Scanalytics Inc.). Blots were subsequently normal-
ized to the loading control GAPDH (1/30 000, HyTest Ltd). In
addition, enzyme activities for citrate synthase and catalase
were measured spectrophotometrically, as previously
described in detail.13 Protein and enzyme activity data are
presented as the fold change relative to the respective control
group. The left soleus was also immediately frozen in liquid N2
and underwent the same molecular analyses as described for
the diaphragm.
An additional piece of diaphragm was also ﬁxed in 4% PBS-
buffered formalin and embedded in parafﬁn for subsequent
histological analyses of ﬁber type and cross-sectional area.
Brieﬂy, 3-lm sections were cut, mounted on glass cover slips,
and incubated overnight at 4°C in antibody diluent (Dako) with
primary antibody against myosin slow ﬁbers (M8421, 1/400;
Sigma). After washing with TBST, sections were ﬁrst incu-
bated with ﬂuorescently conjugated (Alexa 488) secondary
antibodies for 1 hour and then underwent further washing,
including once with the dye Hoechst 33342 (1/100, Sigma).
Thereafter, sections were visualized under a ﬂuorescent
microscope where images were captured with ﬁbers merged
with nuclei to establish ﬁber boundaries (blue), with all stained
ﬁbers taken as type I (bright green) and all unstained ﬁbers
taken as type II (dark green), allowing ﬁber type and size to be
determined.
Statistical Analyses
Analyses were performed by SPSS version 22 (SPSS
Institute Inc). Data are presented as meanSEM. Between-
group differences were assessed by unpaired Student t test
at 20 weeks or by 1-way ANOVA at 28 weeks. Muscle
function (force-frequency and force-time relationships) was
assessed by 2-way repeated measures ANOVA (group9fre-
quency or group9time). Post hoc comparisons were calcu-
lated using Bonferroni test. Data that failed normality
(Kolmogorov and Smirnov) or equal variance tests were
compared by Mann-Whitney (20 weeks) or Kruskal-Wallis
test with Dunn post hoc (28 weeks). Signiﬁcance was
accepted as P<0.05.
Results
Obese ZSF1 Rats Develop HFpEF and an
Oxidative Fiber Hypertrophy and Phenotype in
the Diaphragm
As expected, at 20 weeks of age, obese rats showed evidence
of HFpEF compared with lean controls (Figure 2). Speciﬁcally,
when compared with controls, obese rats developed typical
features associated with the HFpEF syndrome, which included
diastolic dysfunction (conﬁrmed by both noninvasive and
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Figure 2. Animal model characteristics at 20 weeks, which demonstrates that a typical heart failure with
a preserved ejection fraction (HFpEF) phenotype was developed in obese rats compared with lean controls
(Con). HFpEF was conﬁrmed by measures of diastolic dysfunction (A and B) in the presence of normal
systolic function (C) in parallel with a cardiac hypertrophy (D). In the absence of an increase in systolic
blood pressure (SBP) (E), other comorbidities were developed in HFpEF rats including hyperglycemia (F) and
obesity (G), as well as an impaired exercise capacity (H). Data are presented as meanSEM, with n=8 for
Con and n=12 for HFpEF, analyzed with unpaired t test. *P<0.05 vs Con. E/E0 indicates early mitral ﬂow to
tissue velocity; LVEF, left ventricular ejection fraction; LVEDP, left ventricular end-diastolic pressure; LV/TL,
left ventricle/tibial length; _VO2peak, peak oxygen uptake.
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invasive measures of E/E0 and LV end-diastolic pressure,
respectively; Figure 2A and 2B), a preserved LV ejection
fraction (Figure 2C), and LV hypertrophy (Figure 2D), although
lung wet to dry ratio was unchanged between the groups
(P>0.05). The cardiac alterations occurred in the presence of
multiple comorbidities, including hyperglycemia (Figure 2F)
and obesity (Figure 2G). Importantly, obese rats also demon-
strated a reduced exercise capacity by 10% compared with
controls (P<0.05) (Figure 2H). In addition and compared with
controls, while further echocardiographic measures found
that obese animals had an unchanged E/A ratio (1.20.1
versus 1.40.1; P>0.05), invasive hemodynamics revealed
both an increased LV dP/dtmax (7794469 mm Hg/s
versus 9488382 mm Hg/s; P<0.05) and s (12.20.4 ms
versus 13.90.4 ms; P<0.01), while the LV dP/dtmin
remained unaltered (8745721 mm Hg/s versus 8892
296 mm Hg/s; P>0.05). Overall, therefore, these data
provide strong evidence that at 20 weeks of age, obese
ZSF1 rats developed a similar phenotype to that observed in
patients with HFpEF.
At 20 weeks, HFpEF also induced numerous alterations in
the diaphragm, which included a hypertrophy of type I ﬁbers
by 23% (Figure 3C) that corresponded to a decrease of 25%
in the expression of the atrophy-related proteins MuRF1
(P=0.065) (Figure 3E) and MuRF2 (P<0.01) (Figure 3F),
respectively, with a downregulation of MuRF1 levels inversely
correlated to type I ﬁber size in the HFpEF rats (P=0.01;
R2=0.51). In addition, HFpEF also induced a shift towards an
oxidative phenotype, such that the proportion of type I ﬁbers
increased by 23% (P<0.05) (Figure 4A and 4B) in parallel to an
increase in markers of mitochondrial content and antioxidant
capacity in the diaphragm: PGC1-a protein content and citrate
synthase activity were elevated by 51% (P<0.01) (Figure 4C)
and 19% (P<0.05) (Figure 4D), respectively, while catalase
activity was increased by 68% compared with controls
(P<0.01) (Figure 4E). Nevertheless, despite these apparent
quantitative improvements, mitochondrial respiration
assessed in diaphragm ﬁbers revealed signiﬁcant qualitative
impairments, with HFpEF speciﬁcally increasing the leak state
by 30% (P<0.05; Figure 4F) and reducing the respiratory
control ratio by 20%—indicative of an impaired mitochondrial
coupling efﬁciency (P<0.05) (Figure 4G). While no signiﬁcant
differences were discerned between groups in terms of
protein expression for contractile proteins (myosin heavy
chain and actin), markers of oxidative stress (NOX2), and
other atrophy-related proteins (MAFbx; data not shown), mild
impairments to diaphragm contractile function were induced
by HFpEF, which included a reduced twitch tension by 20%
(P<0.05; 4.80.3 N/cm2 versus 4.00.3 N/cm2, respec-
tively) and trend for maximal force to be reduced by 10%
(P=0.07; 221 N/cm2 versus 191 N/cm2, respectively). In
contrast, fatigability was not different between groups, with
relative force generation (normalized to initial force)
unchanged at the end of a 5-minute protocol (161% versus
181%; P>0.05).
Effects of Exercise Training on the HFpEF
Phenotype and on Diaphragm Alterations
Given the molecular and functional alterations we observed
in the diaphragm at 20 weeks in rats with HFpEF, we next
assessed whether these could be reversed by 8 weeks of
exercise training (ie, in the form of secondary prevention by
using HIIT or MCT). As anticipated, at 28 weeks, sedentary
obese rats still presented with typical HFpEF signs, but
these were not inﬂuenced by exercise training, which
included no change in diastolic function (E/E0 and LV end-
diastolic pressure; Figure 5A and 5B), systolic function
(Figure 5C), or LV mass (Figure 5D), alongside no alter-
ations in measures of multiple comorbidities, which
included body weight remaining unchanged (Figure 5E
through 5G). In addition, further echocardiographic mea-
sures found no differences between sedentary, HIIT, or MCT
HFpEF rats in terms of the E/A ratio (1.40.1, 1.40.1,
and 1.50.1, respectively; P>0.05), while invasive hemody-
namics also revealed no differences in terms of the LV dP/
dtmax (8841181, 8146283, and 8239306 mm Hg/s,
respectively; P>0.05), dP/dtmin (9005238, 8267346,
and 8558427 mm Hg/s, respectively; P>0.05), and s
(14.80.4, 15.50.7, and 16.01.1 ms, respectively;
P>0.05). As such, exercise training apparently had limited
beneﬁts on hemodynamics, cardiac remodeling, and comor-
bidities in this rat model of HFpEF. In contrast, however,
both HIIT and MCT were able to signiﬁcantly increase
exercise capacity as compared with sedentary HFpEF rats,
with _VO2peak increased by 15% in both of the exercise
trained groups (P<0.05; Figure 5H).
We next assessed the diaphragm from HFpEF rats at
28 weeks of age and found that exercise training had, in
general, no signiﬁcant effect on most measures that were
shown to be altered at 20 weeks: ﬁber size remained
unchanged (1500 and 2000 lm2 for type I and type II
ﬁbers across all groups, respectively; P>0.05) (Figure 6D
and 6E) while protein expression of MuRF1 and MuRF2 as
markers of atrophy were not different after exercise training
(P>0.05) (Figure 6F and 6G). Similarly, no ﬁber type shift
was evident following exercise training (all groups demon-
strated 40% type I and 60% type II ﬁber proportions;
P>0.05) (Figure 7A and 7B), while quantitative markers of
mitochondrial density including PGC1-a protein content
(Figure 7C), citrate synthase activity (Figure 7D), and cata-
lase activity (Figure 7E) were not different between the
HFpEF groups assigned to either the sedentary, HIIT, or
MCT regimens (all P>0.05) (Figure 7A through 7E). While
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HIIT tended (P=0.06) to improve mitochondrial function by
17% in terms of increasing the respiratory control ratio
when compared with sedentary HFpEF rats (only a 5%
increase was observed after MCT), no signiﬁcant differences
were otherwise detected (Figure 7F and 7G). Not surpris-
ingly, therefore, exercise training had no beneﬁt on
contractile function (P>0.05) (Figure 8A) or on ﬁber fatiga-
bility in HFpEF (P>0.05) (Figure 8B).
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Figure 3. Representative immunoﬂuorescence sections of the diaphragm from control (Con; A) and heart
failure with a preserved ejection fraction (HFpEF) (B) rats at 20 weeks, where sections were incubated with
an antibody against myosin slow type I ﬁbers to allow detection of type I (bright green) and type II (dark
green) ﬁber proportion and size, with cell nuclei stained (blue) to establish ﬁber boundaries (scale bars
represent 100 lm). The ﬁber cross-sectional area (CSA) was increased in type I ﬁbers in the diaphragm
from HFpEF rats (C), with no effects observed for the type II isoform (D). Protein expression of MuRF1 (E)
and MuRF2 (F) was also lower in HFpEF, with both proteins implicated in cooperating to regulate ﬁber size.
The abbreviations C and H for Western blot lanes represent loaded samples from Con and HFpEF,
respectively, with GAPDH used as a loading control. Data are presented as meanSEM, analyzed with
unpaired t test or Mann-Whitney (type I CSA), with n=8 for Con and n=12 for HFpEF. *P<0.05 vs Con.
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Figure 4. Heart failure with a preserved ejection fraction (HFpEF) induced a shift towards an oxidative phenotype in the diaphragm compared
with controls (Con), with a greater proportion of type I (A) and lower proportion of type II ﬁbers (B) at 20 weeks (see Figure 3A and 3B for
representative diaphragm sections). This was associated with a greater peroxisome proliferator-activated receptor gamma coactivator 1-a
(PGC1-a) protein expression (C) as well as citrate synthase (D) and catalase enzyme activity (E). In contrast, in situ mitochondrial respiration
revealed functional deﬁcits in the diaphragm of HFpEF rats, with an increased leak state (LCI) (F) and impaired mitochondrial coupling efﬁciency
(respiratory control ratio [RCR]) (G). Respiration states assessed, in turn, included: LCI, complex I leak respiration following addition of malate
and glutamate; PCI, complex I phosphorylated state following addition of ADP; PCI+II, complex II phosphorylated state following addition of
succinate. RCR (ie, PCI/LCI) and substrate control ratio (SCR; ie, PCI/PCI+II). The abbreviations C and H for Western blot lanes represent loaded
samples from Con and HFpEF, respectively, with GAPDH used as a loading control. Data are presented as meanSEM, analyzed with unpaired t
test, with n=8 for Con and n=12 for HFpEF. *P<0.05 vs Con.
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Figure 5. Animal model characteristics at 28 weeks, which demonstrates the heart failure
with a preserved ejection fraction (HFpEF) phenotype in sedentary (Sed) obese rats was
generally not inﬂuenced by 8 weeks of either high-intensity interval training (HIIT) or
moderate-continuous training (MCT). Compared with sedentary HFpEF rats, exercise training
did not inﬂuence cardiac measures of diastolic (A and B) or systolic function (C), cardiac
hypertrophy (D), or multiple comorbidities such as hypertension (E), hyperglycemia (F), and
obesity (G). Importantly, however, both exercise training interventions of HIIT and MCT
improved exercise capacity compared with the sedentary HFpEF condition (H). Data are
presented as meanSEM, with n=13 for Sed, n=11 for HIIT, and n=11 for MCT, analyzed with
1-way ANOVA or Kruskal-Wallis test with Dunn post hoc (glucose and _VO2peak). *P<0.05 vs
Sed, §P<0.05 vs HIIT. E/E0 indicates early mitral ﬂow to tissue velocity; LVEF, left ventricular
ejection fraction; LVEDP, left ventricular end-diastolic pressure; LV/TL, left ventricle/tibial
length; SPB, systolic blood pressure; _VO2peak, peak oxygen uptake.
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Figure 6. Representative immunoﬂuorescence sections of the diaphragm at 28 weeks from heart failure with a
preserved ejection fraction (HFpEF) rats that remained sedentary (Sed; A) or performed 8 weeks of high-intensity interval
training (HIIT; B) or moderate-continuous training (MCT; C), where sections were incubated with an antibody against
myosin slow type I ﬁbers to allow detection of type I (bright green) and type II (dark green) ﬁber proportion and size, with
cell nuclei stained (blue) to establish ﬁber boundaries (scale bar represents 100 lm). Exercise training in HFpEF rats that
performed HIIT or MCT had no effect on ﬁber cross-sectional area (CSA) in both type I (D) and II (E) isoforms compared
with their sedentary counterparts. Similarly, exercise training had no effect on the protein expression of either MuRF1 (F)
or MuRF2 (G). The abbreviations S, H, and M for Western blot lanes represent loaded samples from HFpEF in the
sedentary (S), HIIT (H), or MCT (M) groups, respectively, with GAPDH used as a loading control. Data are presented as
meanSEM, analyzed with 1-way ANOVA, with n=13 for Sed, n=11 for HIIT, and n=11 for MCT.
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Figure 7. In heart failure with a preserved ejection fraction (HFpEF) rats at 28 weeks, ﬁber type proportion in the diaphragm for
type I (A) and II (B) isoforms was not inﬂuenced following either high-intensity interval training (HIIT) or moderate-continuous
training (MCT) when compared with sedentary (Sed) controls (see Figure 6A through 6C for representative diaphragm sections).
Similarly, markers of mitochondrial content remained unchanged, including the protein expression of peroxisome proliferator-
activated receptor gamma coactivator 1-a (PGC1-a) (C) and enzyme activities of both citrate synthase (D) and catalase (E), as were
functional measures of mitochondrial respiration (F) and the respective control ratios (G). Respiration states assessed, in turn,
included: LCI, complex I leak respiration following addition of malate and glutamate; PCI, complex I phosphorylated state following
addition of ADP; PCI+II, complex II phosphorylated state following addition of succinate. The abbreviations S, H, and M for Western
blot lanes represent loaded samples from HFpEF rats in the sedentary (S), HIIT (H), or MCT (M) groups, respectively, with GAPDH
used as a loading control. Data are presented as meanSEM, analyzed with 1-way ANOVA, with n=13 for Sed, n=11 for HIIT, and
n=11 for MCT. RCR indicates respiratory control ratio; SCR, substrate control ratio.
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Limb Skeletal Muscle Alterations in HFpEF
In addition, we also assessed alterations in the soleus limb
muscle, both at 20 and 28 weeks, in order to provide a
comparison to the diaphragm (Figure 9). At 20 weeks, while
contractile function and fatigability remained unaltered
(P>0.05) (Figure 9A and 9B), muscle atrophy was present
in HFpEF rats with muscle mass reduced by 15% (P>0.05)
(Figure 9C). Further assessment of the molecular alterations
revealed that mitochondrial density, as measured by citrate
synthase activity, tended (P=0.06) to be increased by 45%
in the soleus of HFpEF rats (Figure 9D). Similarly, markers
typically related to the atrophy process were also higher in
HFpEF rats: protein expression of MuRF1 tended to be
increased by 20% (P>0.05) (Figure 9F), while MuRF2
increased by 25% (P<0.05) (Figure 9G). Interestingly, at
28 weeks, sedentary HFpEF rats tended to generate higher
maximal soleus forces (10% higher compared with the
HIIT HFpEF rats; P<0.05) (Figure 9A), with exercise training
also having no inﬂuence on soleus fatigability (P>0.05)
(Figure 9B). In contrast, however, HIIT was able to
attenuate the muscle atrophy induced by HFpEF (P<0.05)
(Figure 9C), while molecular measures following exercise
training tended to be improved, albeit not signiﬁcant: citrate
synthase activity (P=0.07) (Figure 9D) and PGC1-a protein
content (P>0.05) (Figure 9E) tended to be 30% higher in
trained animals, while levels of MuRF1 and MuRF2 were
generally lower by 25% (P>0.05) (Figure 9F and 9G).
Discussion
This study, using a well-characterized rat model of HFpEF
underpinned by multiple comorbidities and exercise intoler-
ance (ie, one that closely resembles the patient phenotype),9–
12 provides the ﬁrst evidence in rats that diaphragm
alterations and dysfunction induced in overt HFpEF were not
reversed following 8 weeks of aerobic exercise training (ie,
secondary prevention). This was observed for both the HIIT
and MCT exercise training regimens, which indicates an
apparent metabolic inﬂexibility of the diaphragm in HFpEF—a
ﬁnding that opposes previous data where exercise training as
primary prevention was beneﬁcial in the period preceding the
development of HFpEF.8 As such, these data may have
important clinical implications for treating respiratory muscle
weakness in patients with HFpEF,6,7 suggesting that alterna-
tive therapeutic interventions may provide greater beneﬁts
compared with aerobic exercise training. Nevertheless, the
ﬁnding that both training regimens still improved exercise
capacity in HFpEF supports the current notion that exercise
training is an effective treatment strategy for the HFpEF
syndrome.2
Does HFpEF Induce a Myopathy in the
Diaphragm?
In contrast to HFrEF,14 the effects of HFpEF on the diaphragm
remain relatively unknown attributable, in part, to this patient
cohort only more recently becoming apparent and the lack of
appropriate animal models. Nevertheless, current evidence
suggests that diaphragm weakness is an important driving
factor that exacerbates the main symptom of exercise
intolerance in patients with HFpEF.6,7 While the underlying
intracellular mechanisms responsible for diaphragm dysfunc-
tion in HFpEF remain poorly explored, our laboratory recently
provided initial evidence using a hypertensive rat model of
HFpEF.8,15 Indeed, and consistent with the present study, rats
A
B
0 60 120 180 240 300
0
25
50
75
100
HFpEF
Sed
HIIT
MCT
Time, s
R
el
at
iv
e 
Fo
rc
e,
 %
0 25 50 75 100 125 150
0
5
10
15
20
25
30
Sed
HIIT
MCT
HFpEF
Frequency, Hz
Sp
ec
ifi
c
Fo
rc
e,
N
/c
m
2
Figure 8. In vitro diaphragm function at 28 weeks in heart
failure with a preserved ejection fraction (HFpEF) rats assessed in
isolated ﬁber bundles revealed that compared with sedentary
(Sed) rats, the interventions of high-intensity interval training
(HIIT) or moderate-continuous training (MCT) had no beneﬁts on
contractile function (A) or fatigue resistance (B). Data are
presented as meanSEM, analyzed with 2-way repeated mea-
sures ANOVA, with n=13 for Sed, n=11 for HIIT, and n=11 for
MCT.
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with HFpEF also had a shift towards a type I ﬁber proportion,
an increase in mitochondrial quantitative markers despite
impaired qualitative function, and a reduction in maximal
contractile function.8,15
However, our previous animal model used Dahl salt-
sensitive rats—a model where HFpEF was driven exclusively
by hypertension in the absence of the main symptom exercise
intolerance.8,15 In the present study, ZSF1 rats were used
where multiple comorbidities are developed (eg, obesity,
diabetes mellitus, hypertension, chronic kidney disease) as
well as exercise intolerance,9–12 thus more closely reﬂecting
the HFpEF patient phenotype. This may explain, at least in
part, why the current obese HFpEF animals demonstrated an
20% type I ﬁber hypertrophy and no impairment to fatiguing
contractions, which is in contrast to our hypertensive HFpEF
model where a ﬁber atrophy of 30% was observed with
greater fatigability.8 These opposing ﬁndings are likely related
to the obesity developed in the present animal model, which
is prevalent in >80% of patients with HFpEF.4 Obesity is
known to elevate the mechanical work of breathing that is
suggested to drive a ﬁber hypertrophy and increase mito-
chondrial oxidative capacity, thereby allowing the muscle to
become more resistant to fatigue.16,17 Indeed, a greater
proportion of type I ﬁbers are assumed not only to increase
the efﬁciency of ATP hydrolysis,18 which may, in turn, delay
fatigue, but also reduce isometric force generation caused by
Figure 9. Alterations induced by heart failure with a preserved ejection fraction (HFpEF) in the soleus
limb muscle at 20 weeks (control [Con] vs HFpEF) and also following 8 weeks of exercise training at
28 weeks (HFpEF rats that were sedentary [Sed] or performed high-intensity interval training [HIIT] or
moderate-continuous training [MCT]), where in vitro maximal force generation (A) and fatigability (B) were
assessed, followed by tissue analyses including muscle wet-weight normalized to tibia length (TL) (C),
citrate synthase activity (D), and peroxisome proliferator-activated receptor gamma coactivator 1-a
(PGC1-a) protein expression (E) as indices of mitochondrial density, and the expression of proteins
involved in the muscle remodeling process MuRF1 (F) and MuRF2 (G). Proteins of interest were normalized
to loading control GAPDH, with representative Western blot data shown in (H). At 20 weeks, HFpEF
induced no functional alterations (A and B) but did reduce muscle mass (C), which was associated with a
higher citrate synthase activity (D) and a trend for atrogins MuRF1 and MuRF2 to be increased (F and G).
At 28 weeks, exercise training in HFpEF tended to increase muscle mass (C) and mitochondrial markers
(D and E) and reduce the expression of atrogins (F and G). Data are presented as meanSEM, analyzed
with unpaired t test (or Mann-Whitney for soleus force and weight measures) at 20 weeks or 1-way
ANOVA (Bonferroni post hoc) at 28 weeks, with n=8 for Con and n=12 for HFpEF at 20 weeks, while n=13
for Sed, n=11 for HIIT, and n=11 for MCT in HFpEF rats at 28 weeks. *P<0.05 vs Con. §P<0.05 vs Sed.
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type I compared with type II ﬁbers generating lower speciﬁc
forces.19 The latter may provide a partial explanation for the
lower contractile forces we observed in the HFpEF rats
compared with controls at 20 weeks, although single ﬁber
analyses are required to answer this suggestion indeﬁnitely. In
addition, the type I ﬁber hypertrophy we observed in the
diaphragm of our obese HFpEF rats was also associated with
a reduction in the atrophy-related proteins MuRF1 and
MuRF2, which may suggest a role for the MuRF family of
proteins in mediating this effect. That is, a lower protein
expression of both MuRF1 and MuRF2 in the diaphragm would
be predicted to downregulate pathways related to protein
degradation and upregulate pathways related to protein
synthesis. Indeed, previous evidence has shown that genetic
deletion of both MuRF1 and MuRF2 cooperatively induce a
ﬁber hypertrophy,20 while the MuRF proteins have also been
implicated as regulators of protein synthesis and energy
metabolism.20,21 As such, the increased work of breathing
consequent to obesity in HFpEF may provide some partial
protection against ﬁber atrophy in the diaphragm that acts to
maintain muscle function.
Despite the shift towards an oxidative phenotype, we still
observed functional mitochondrial impairments, which
included a higher leak state and an apparent reduction in
mitochondrial coupling efﬁciency (ie, a lower respiratory
control ratio). Previous data from rat skeletal muscle have
shown that when mitochondrial proton ﬂow is uncoupled
from oxidative phosphorylation using 2, 4-dinitrophenol, a
higher leak state and reduced mitochondrial efﬁciency is
observed and corresponds to an increase in markers of
mitochondrial content and a shift towards an oxidative ﬁber
proportion.22 As such, whether a greater work of breathing
or rather an increase in mitochondrial uncoupling mediated
the shift towards an oxidative phenotype in the diaphragm of
our HFpEF rats remains a matter of debate, but further
research is clearly warranted. Despite the increase in
mitochondrial quantitative measures, the functional mito-
chondrial deﬁcits in combination with the ﬁber contractile
impairments in HFpEF rats support the assumption that an
underlying myopathy may occur in HFpEF—a suggestion
reinforced by our ﬁndings that exercise training was unable
to provide any beneﬁcial effects in the diaphragm. Clearly,
however, more evidence is still required from animal models
and patient biopsies to better understand the intracellular
perturbations associated with diaphragm dysfunction in
HFpEF.
Does Exercise Training Improve Diaphragm
Function in HFpEF?
At present, unlike many drug-based treatments, aerobic
exercise training seems to be one of the few effective
Figure 9. Continued.
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therapies available for treating patients with HFpEF.2 In the
present study, our main focus was to closely mirror the
clinical situation, where patients commonly begin exercise
training once HFpEF has been diagnosed (ie, secondary
prevention). As such, we initially allowed our rats to
develop the HFpEF syndrome over 20 weeks, which is
consistent with earlier studies.9–12 Based on our previous
study where exercise training (ie, HIIT) performed in the
period preceding HFpEF development was able to attenuate
diaphragm dysfunction and normalize mitochondrial func-
tion,8 we also expected to see a similar response in the
current study. To our surprise, however, exercise training
had no apparent beneﬁts on the diaphragm, at least in
relation to the measures we performed, and thus was
unable to reverse the functional impairments we also
observed at 20 weeks. Furthermore, these ﬁndings were
independent of the training regimen as both HIIT and MCT
were ineffective. The intensity of the exercise was appar-
ently adequate, as previous evidence has shown this
intensity of the HIIT protocol is able to induce positive
alterations in the diaphragm,8 while _VO2peak was improved
in both trained groups compared with sedentary HFpEF
rats. Overall, therefore, these data seem to suggest that in
HFpEF, a certain degree of metabolic inﬂexibility may exist
that prevents the diaphragm from responding to the stress
of exercise training.
Whether these ﬁndings also translate to patients
remain to be determined, but they suggest that following
the development of overt HFpEF, aerobic exercise training
may be ineffective in reversing diaphragm weakness.
Intriguingly, exercise capacity still increased in HFpEF rats
that performed the HIIT or MCT compared with their
sedentary counterparts, which suggests that improve-
ments in vascular and/or limb muscle function were
likely responsible (discussed below in more detail). Indeed,
as exercise training in our HFpEF rats also had no
beneﬁts on cardiac parameters supports previous patient
data,5 where cardiac function was also not inﬂuenced. As
such, the present study seems to support a role that
improvements in limb skeletal muscle and/or vascular/
endothelial function may be the primary mechanism that
allows exercise capacity to be elevated following exercise
training in HFpEF.
Limb Muscle Alterations in HFpEF
In order to provide a comparison to the diaphragm, we also
analyzed a limb muscle—the soleus. It has been suggested
that in HFrEF, the diaphragm may be more sensitive to
alterations compared with limb muscle23; however, with
regards to HFpEF, initial evidence indicates that the limb
muscles may be similarly affected.8 While we found no
obvious functional deﬁcits in the soleus muscle from the
current group of obese HFpEF rats (ie, contractile function
and fatigue indices remained unchanged), we did reveal
numerous tissue alterations such that at 20 weeks an 15%
muscle atrophy was present and this was associated with an
upregulation in atrogins (ie, the MuRF1 and MuRF2), while
mitochondrial capacity (as inferred from citrate synthase
activity) tended to be higher in HFpEF rats compared with
controls. The latter may suggest a potential compensatory
response to the obese phenotype attributable to a reduction
in blood ﬂow or consequent to an increase in weight-bearing
load. Indeed, this suggestion is supported by previous data
whereby obesity was shown to increase measures of oxidative
capacity in numerous limb muscles.24 Yet, and in contrast,
biopsies collected from limb muscle in patients with HFpEF
recently reported that mitochondrial content and oxidative
capacity were reduced.25 However, as this patient cohort
were widely heterogeneous, older, and not primarily charac-
terized by obesity,25 whether our current ﬁndings translate to
patients remains to be determined.
In addition, and similar to the diaphragm, the present study
found that exercise training had limited beneﬁts onmost soleus
tissue indices in HFpEF rats, although the HIIT intervention was
clearly able to attenuate the muscle atrophy observed in
sedentary HFpEF rats. This was associated with a trend for
levels of atrogins (MuRF1 and MuRF2) to be reduced and
mitochondrial markers (PGC1-a and citrate synthase) to be
increased. Collectively, therefore, these data conﬁrm that in an
obese model of HFpEF, numerous alterations in limb skeletal
muscle are induced, with evidence demonstrating that HIIT may
provide an intervention to reverse potential underlying impair-
ments, which, in turn, may contribute to improving exercise
capacity following training. Alternatively, the primary mecha-
nism that may have underpinned the increase in exercise
capacity in HFpEF following the HIIT or MCT regimens may be
directly related to improvements in endothelial function. It is
well established that HFpEF can induce endothelial dysfunc-
tion, with available evidence showing that this can be reversed
by exercise training.26 While inclusion of endothelial measure-
ments was beyond the scope of the present study, where the
main interest was to investigate the diaphragm, the potential
for exercise training to improve peripheral endothelial function
remains likely. The latter would be predicted to elevate O2
diffusion from capillary to myocyte, thereby driving improve-
ments in subsequent exercise capacity27—a ﬁnding that was
observed in the present study following 8 weeks of exercise
training.
Study Limitations
While the present study assessed the effects of HFpEF in
ZSF1 rats at one of the most advanced time points yet
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studied (ie, 28 weeks of age), whether these ﬁndings
translate to the typically elderly HFpEF population remains
unclear. In addition, whether our ﬁndings can be generalized
to the more general female HFpEF population is unknown,
with only male rats used in the present study. We also only
assessed the effects of aerobic exercise training and thus it
remains unclear whether other training modalities such as
respiratory muscle training may have greater beneﬁts on
diaphragm function. Further, we also did not systemically
evaluate food intake in the current study, which may have
provided useful insight into the caloric response to exercise
training in HFpEF.
Conclusions
Diaphragm alterations induced by an obesity-driven rat model
of HFpEF were not reversed following 8 weeks of aerobic
exercise training, which suggests alternative therapeutic
interventions may be required to treat respiratory muscle
weakness in patient resembling this phenotype.
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